N-Acetyl Semax Amidate: Structural Modification and Research Implications
N-Acetyl Semax Amidate represents a dual-terminal modification of the parent Semax heptapeptide — N-terminal acetylation combined with C-terminal amidation — producing measurably greater enzymatic resistance and altered receptor interaction profiles compared to the unmodified sequence. This article examines the molecular rationale behind each modification, the pharmacokinetic consequences documented in peptide stability research, and the implications for neuropeptide analog design.